Zwe-Ling Kong

Title: Innovations by Zwe-Ling Kong in Blood Glucose Regulation

Introduction

Zwe-Ling Kong is a notable inventor based in Yilan County, Taiwan. He has made significant contributions to the field of medical science, particularly in the regulation of blood glucose levels. With a total of 2 patents, his work focuses on innovative methods that can potentially improve the health of individuals with glucose regulation issues.

Latest Patents

Zwe-Ling Kong's latest patents include a method for regulating blood glucose levels. This method involves increasing the expression of SIRT1 mRNA and/or decreasing the expression of SOCS3 mRNA. The approach is designed for subjects in need of blood glucose regulation. The method comprises administering an effective amount of an active component selected from a specific group of compounds. The details of the compounds include a formula (I) and its pharmaceutically acceptable salts, along with various combinations thereof.

Career Highlights

Zwe-Ling Kong is associated with Sinphar Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovations. His work is crucial in developing new therapeutic methods that can aid in managing blood glucose levels effectively.

Collaborations

Some of his notable coworkers include Fan-Chi Ko and Ai-Ling Yeh, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Zwe-Ling Kong's innovative methods for regulating blood glucose levels represent a significant advancement in medical science. His contributions through patents and collaboration with colleagues highlight the importance of research in improving health outcomes.